Chronic ischaemic heart disease in the elderly

被引:2
|
作者
Martinez-Selles, Manuel [1 ,2 ]
Gomez Huelgas, Ricardo [3 ]
Abu-Assi, Emad [4 ,5 ]
Calderon, Alberto [6 ]
Teresa Vidan, Maria [7 ]
机构
[1] Univ Europea, Hosp Gen Univ Gregorio Maranon, Serv Cardiol, SEC,Secc Cardiol Geriatr, Madrid, Spain
[2] Univ Complutense, E-28040 Madrid, Spain
[3] Fdn Publ Andaluza Invest Malaga Biomed & Salud FI, Hosp Univ Reg Malaga, Dept Med Interna, SEMI, Malaga, Spain
[4] Hosp Clin Univ Santiago de Compostela, Serv Cardiol, Secc Cardiopatia Isquem & Cuidados Agudos Cardiov, SEC, Santiago De Compostela, A Coruna, Spain
[5] Hosp Clin Univ Santiago de Compostela, Unidad Coronaria, Santiago De Compostela, A Coruna, Spain
[6] Soc Espanola Med Atenc Primaria SEMERGEN, Ctr Salud Rosa Luxemburgo, Madrid, Spain
[7] Univ Complutense, Hosp Gen Univ Gregorio Maranon, Serv Geriatria, SEGG, E-28040 Madrid, Spain
来源
MEDICINA CLINICA | 2016年 / 146卷 / 08期
关键词
Comorbidity; Elderly; Ischemic heart disease;
D O I
10.1016/j.medcli.2016.01.014
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
It is the aim of this manuscript to take into account the peculiarities and specific characteristics of elderly patients with chronic ischaemic heart disease from a multidisciplinary perspective, with the participation of the Spanish Society of Cardiology (sections of Geriatric Cardiology and Ischaemic Heart Disease/Acute Cardiovascular Care), the Spanish Society of Internal Medicine, the Spanish Society of Primary Care Physicians and the Spanish Society of Geriatrics and Gerontology. This consensus document shows that in order to adequately address these elderly patients a comprehensive assessment is needed, which includes comorbidity, frailty, functional status, polypharmacy and drug interactions. We conclude that in most patients medical treatment is the best option and that this treatment must take into account the above factors and the biological changes associated with aging. © 2016 Elsevier España, S.L.U. All rights reserved.
引用
收藏
页码:372 / 372
页数:1
相关论文
共 50 条
  • [1] Thyroxine replacement and ischaemic heart disease in the elderly
    Trescoli-Serrano, C
    Tulloch, J
    [J]. AUSTRALIAN JOURNAL ON AGEING, 1998, 17 (02): : 97 - 98
  • [2] Lipids in elderly patients with ischaemic heart disease
    Tereshina, H. V.
    Pleteneva, O. P.
    Osokina, N. Ye.
    [J]. ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 189 - 189
  • [3] Ischaemic heart disease in the elderly and referal patterns for revascularisation
    Snowdon, R
    Lowe, R
    Perry, RA
    [J]. EUROPEAN HEART JOURNAL, 2002, 23 : 503 - 503
  • [4] Chronic ischaemic heart disease: Intracoronary Imaging
    Giavarini, Alessandra
    Kilic, Ismail Dogu
    Redondo Dieguez, Alfredo
    Longo, Giovanni
    Vandormael, Isabelle
    Pareek, Nilesh
    Kanyal, Ritesh
    De Silva, Ranil
    Di Mario, Carlo
    [J]. HEART, 2017, 103 (09) : 708 - 725
  • [5] Ischaemic heart disease in patients on chronic hemodialysis
    Baldovinos, G
    Petraglia, A
    Borges, PL
    Alvarez, A
    Mizraji, R
    Sanz, A
    Ferreiro, A
    Moreno, M
    Nin, M
    González, F
    [J]. NEFROLOGIA, 2002, 22 (01): : 60 - 65
  • [6] Impact of renal function on the prognostic value of mineral metabolism in patients with chronic ischaemic heart disease patients with chronic ischaemic heart disease
    Acena, Alvaro
    Maria Pello-Lazaro, Ana
    Martinez-Milla, Juan
    Gonzalez-Lorenzo, Oscar
    Tarin, Nieves
    Cristobal, Carmen
    Blanco-Colio, Luis M.
    Luis Martin-Ventura, Jose
    Huelmos, Ana
    Lopez-Castillo, Marta
    Alonso, Joaquin
    Gutierrez-Landaluce, Carlos
    Lopez Bescos, Lorenzo
    Alonso-Pulpon, Luis
    Gonzalez-Parra, Emilio
    Egido, Jesus
    Mahillo-Fernandez, Ignacio
    Lorenzo, Oscar
    Luisa Gonzalez-Casaus, Maria
    Tunon, Jose
    [J]. CLINICA E INVESTIGACION EN ARTERIOSCLEROSIS, 2022, 34 (01): : 1 - 9
  • [7] Elderly patients with ischaemic heart disease need our attention!
    Bjarnason-Wehrens, Birna
    [J]. EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2018, 25 (03) : 276 - 277
  • [8] Evaluation of effectiveness of rehabilitation in elderly patients with ischaemic heart disease
    Sameniene, J
    Dragunevieiene, R
    Janenaite, J
    Savickas, R
    [J]. GERONTECHNOLOGY: A SUSTAINABLE INVESTMENT IN THE FUTURE, 1998, 48 : 313 - 316
  • [9] Gene and cell therapy for chronic ischaemic heart disease
    Poh, Kian-Keong
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2007, 7 (01) : 5 - 15
  • [10] ICF core sets for chronic ischaemic heart disease
    Cieza, A
    Stucki, A
    Geyh, S
    Berteanu, M
    Quittan, M
    Simon, A
    Kostanjsek, N
    Stucki, G
    Walsh, N
    [J]. JOURNAL OF REHABILITATION MEDICINE, 2004, 36 : 94 - 99